← Eichor
Study identifier: NCT05462587 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study to Evaluate Efficacy and Safety of AVTX-803 in Patients With Leukocyte Adhesion Deficiency Type II

Condition: Leukocyte Adhesion Deficiency  ·  Sponsor: AUG Therapeutics

PhasePhase 3
Planned participants4
Who can joinAll sexes, 6 Months to 75 Years
Healthy volunteersNo

About this study

The primary objective of this study is to evaluate the efficacy and safety of AVTX-803 compared to withdrawal in patients with Leukocyte Adhesion Deficiency, Type II (LAD II).

This description comes directly from the study's public registry record.

Talk to the study team

Jennifer Lin  ·  3052833827  ·  huiyil@augtx.com

Always discuss trial participation with your own doctor first.

Locations (1)

Mayo ClinicRochester, Minnesota, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05462587